P. R. Deepa

1.5k total citations
76 papers, 1.2k citations indexed

About

P. R. Deepa is a scholar working on Molecular Biology, Cancer Research and Epidemiology. According to data from OpenAlex, P. R. Deepa has authored 76 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Molecular Biology, 15 papers in Cancer Research and 12 papers in Epidemiology. Recurrent topics in P. R. Deepa's work include Peroxisome Proliferator-Activated Receptors (11 papers), Cancer, Lipids, and Metabolism (10 papers) and Ocular Oncology and Treatments (8 papers). P. R. Deepa is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (11 papers), Cancer, Lipids, and Metabolism (10 papers) and Ocular Oncology and Treatments (8 papers). P. R. Deepa collaborates with scholars based in India, Australia and United Kingdom. P. R. Deepa's co-authors include Palaninathan Varalakshmi, Subramanian Krishnakumar, Pankaj Kumar Sharma, U Jayanthi, Vikas Khetan, HN Madhavan, Nalini Venkatesan, R Bagyalakshmi, Umashankar Vetrivel and K. Lily Therese and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Journal of Cleaner Production.

In The Last Decade

P. R. Deepa

66 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. R. Deepa India 22 428 178 139 133 108 76 1.2k
Qi Zhou China 20 666 1.6× 127 0.7× 82 0.6× 141 1.1× 48 0.4× 81 1.3k
So Young Kim South Korea 23 656 1.5× 134 0.8× 158 1.1× 81 0.6× 47 0.4× 69 1.4k
Shuang Jiang China 27 972 2.3× 123 0.7× 228 1.6× 122 0.9× 34 0.3× 65 1.7k
Ram Prasad United States 25 747 1.7× 202 1.1× 75 0.5× 121 0.9× 32 0.3× 59 1.4k
Yuan‐Yen Chang Taiwan 29 746 1.7× 158 0.9× 303 2.2× 285 2.1× 60 0.6× 81 2.0k
Yongli Bao China 26 1.1k 2.6× 274 1.5× 108 0.8× 186 1.4× 23 0.2× 107 2.0k
Yi‐Ju Lee Taiwan 24 535 1.3× 97 0.5× 153 1.1× 134 1.0× 30 0.3× 81 1.3k
Roberta Giordo Italy 25 697 1.6× 130 0.7× 88 0.6× 86 0.6× 29 0.3× 56 1.8k
Allan Lançon France 14 638 1.5× 127 0.7× 129 0.9× 132 1.0× 38 0.4× 18 1.3k
Chunlei Yu China 22 656 1.5× 193 1.1× 83 0.6× 100 0.8× 21 0.2× 69 1.3k

Countries citing papers authored by P. R. Deepa

Since Specialization
Citations

This map shows the geographic impact of P. R. Deepa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. R. Deepa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. R. Deepa more than expected).

Fields of papers citing papers by P. R. Deepa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. R. Deepa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. R. Deepa. The network helps show where P. R. Deepa may publish in the future.

Co-authorship network of co-authors of P. R. Deepa

This figure shows the co-authorship network connecting the top 25 collaborators of P. R. Deepa. A scholar is included among the top collaborators of P. R. Deepa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. R. Deepa. P. R. Deepa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
5.
Deepa, P. R., et al.. (2024). An insight into advances and challenges in the development of potential stearoyl Co-A desaturase 1 inhibitors. RSC Advances. 14(41). 30487–30517. 2 indexed citations
6.
Chatterjee, Anwesha, et al.. (2023). Nature-inspired Enzyme engineering and sustainable catalysis: biochemical clues from the world of plants and extremophiles. Frontiers in Bioengineering and Biotechnology. 11. 1229300–1229300. 15 indexed citations
7.
Deepa, P. R., et al.. (2017). Mathematical Modeling of Coronary Artery Disease (CAD): Analysis Reveals HbA1c and Total Cholesterol to be Significant Risk Predictors. Applied mathematics/Applied Mathematics. A Journal of Chinese Universities/Gao-xiao yingyong shuxue xuebao. 7(1). 1–4.
8.
Venkatesan, Nalini, Jagat R. Kanwar, P. R. Deepa, et al.. (2016). Clinico-Pathological Association of Delineated miRNAs in Uveal Melanoma with Monosomy 3/Disomy 3 Chromosomal Aberrations. PLoS ONE. 11(1). e0146128–e0146128. 37 indexed citations
9.
Venkatesan, Nalini, P. R. Deepa, Vikas Khetan, & Subramanian Krishnakumar. (2015). Computational and in vitro Investigation of miRNA-Gene Regulations in Retinoblastoma Pathogenesis: miRNA Mimics Strategy. SHILAP Revista de lepidopterología. 3 indexed citations
10.
Sulochana, Konerirajapuram Natarajan, et al.. (2014). A molecular model of human Lysyl Oxidase (LOX) with optimal copper orientation in the catalytic cavity for induced fit docking studies with potential modulators. Bioinformation. 10(7). 406–412. 21 indexed citations
11.
Coral, Karunakaran, et al.. (2013). Biochemical changes accompanying apoptotic cell death in retinoblastoma cancer cells treated with lipogenic enzyme inhibitors. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1831(9). 1458–1466. 27 indexed citations
12.
Sekar, Sudharshan, et al.. (2012). The Metabolic Advantage of Choline Lactate in Growth Media: An Experimental Analysis with Staphylococcus lentus. Applied Biochemistry and Biotechnology. 169(2). 380–392. 2 indexed citations
13.
Deepa, P. R., et al.. (2011). Therapeutic and Toxicologic Evaluation of Anti‐Lipogenic Agents in Cancer Cells Compared with Non‐Neoplastic Cells. Basic & Clinical Pharmacology & Toxicology. 110(6). 494–503. 54 indexed citations
14.
15.
Therese, K. Lily, et al.. (2010). Antibiotic susceptibility pattern of rapidly growing mycobacteria. Journal of Postgraduate Medicine. 56(2). 76–78. 47 indexed citations
16.
Deepa, P. R., et al.. (2009). Oxidative Stress in Retinoblastoma: Correlations with Clinicopathologic Features and Tumor Invasiveness. Current Eye Research. 34(12). 1011–1018. 11 indexed citations
17.
Deepa, P. R. & Palaninathan Varalakshmi. (2005). Biochemical evaluation of the inflammatory changes in cardiac, hepatic and renal tissues of adriamycin-administered rats and the modulatory role of exogenous heparin-derivative treatment. Chemico-Biological Interactions. 156(2-3). 93–100. 25 indexed citations
18.
Deepa, P. R. & Palaninathan Varalakshmi. (2005). Influence of a low-molecular-weight heparin derivative on the nitric oxide levels and apoptotic DNA damage in adriamycin-induced cardiac and renal toxicity. Toxicology. 217(2-3). 176–183. 24 indexed citations
19.
Deepa, P. R. & Palaninathan Varalakshmi. (2005). Favourable modulation of the inflammatory changes in hypercholesterolemic atherogenesis by a low-molecular-weight heparin derivative. International Journal of Cardiology. 106(3). 338–347. 29 indexed citations
20.
Deepa, P. R. & Palaninathan Varalakshmi. (2003). Salubrious effect of low molecular weight heparin on atherogenic diet-induced cardiac, hepatic and renal lipid peroxidation and collapse of antioxidant defences. Molecular and Cellular Biochemistry. 254(1-2). 111–116. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026